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INTRODUCTION 
 
Tissue regeneration and maintenance dramatically and 
invariably decline with age, eventually causing failure 
of multiple organ systems in all mammals. In muscle, 
the loss of tissue regeneration with age is thought to be 
imposed by signaling changes in the satellite stem cell 
niche, and interestingly, the aging of stem cell niches is 
to some extent similar between muscle, brain, blood, 
and other tissues [1-3]. Our previous work found that 
human embryonic stem cells (hESCs) produce soluble 
secreted molecules that can counteract the age-imposed 
inhibition of muscle regeneration, an “anti-aging” 
activity that is lost when the hESCs differentiate [4, 5].  
 
Numerous mitogenic proteins are expressed by hESCs 
[6] and are known to act through TGF-beta/BMP, Jak-
Stat, MAPK,  and other key  regulatory  signaling  path- 
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ways, all of which have been implicated in the control 
of adult tissue regeneration. The precise identity of the 
pro-myogenic factors that are secreted by hESCs and 
the molecular mechanism of their action in muscle stem 
and progenitor cells is still work in progress; however, 
the effects of one of these molecules, FGF-2, was 
studied here in detail.  FGF-2 is known to be secreted 
by hESCs and is also contained in the growth/expansion 
medium of embryonic stem cells [7-9].  FGF-2 does not 
have a signal peptide and is not secreted through the 
ER-Golgi pathway [10, 11], and the mechanisms of 
FGF-2 transport or export from cells in skeletal muscle 
are not well defined. FGF-2 ligand acts by binding to 
promiscuous receptor complexes to activate the 
MAPK/PERK pathway, which is well known to exert 
strong mitogenic effects and to be necessary for the 
establishment and maintenance of primary cultures of 
muscle progenitor cells [12, 13].   
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Abstract: This  work  builds  upon  our  findings  that  proteins  secreted  by  hESCs  exhibit  pro‐regenerative  activity,  and
determines that hESC‐conditioned medium robustly enhances the proliferation of both muscle and neural progenitor cells.
Importantly,  this work establishes  that  it  is  the proteins  that bind heparin which are  responsible  for  the pro‐myogenic
effects of hESC‐conditioned medium, and  indicates that this strategy  is suitable  for enriching the potentially therapeutic
factors.   Additionally, this work shows that hESC‐secreted proteins act independently of the mitogen FGF‐2, and suggests
that FGF‐2 is unlikely to be a pro‐aging molecule in the physiological decline of old muscle repair. Moreover, hESC‐secreted
factors improve the viability of human cortical neurons in an Alzheimer's disease (AD) model, suggesting that these factors
can enhance the maintenance and regeneration of multiple tissues in the aging body. 
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With age, the activation and proliferation response of 
aged muscle stem cells after injury declines as 
compared to young [14]. Consequentially, the 
generation of fusion-competent muscle progenitor cells, 
or myoblasts, that co-express desmin, Myf5, MyoD and 
Pax-7, incorporate BrdU, and terminally differentiate 
into myotubes or myofibers that express eMyHC, 
becomes deficient in poorly regenerating old tissue [1]. 
Controversially, a recent report [15] suggested that 
FGF-2 is overproduced by aged myofibers and 
subsequently induces proliferation and exhaustion of the 
old satellite cells that are typically quiescent. The age-
specific role of FGF-2 was examined here with respect 
to its localization and signaling in muscle stem cells. 
 
The age-imposed decline in stem cell responses is 
caused by the aging of the niche, not only in muscle, but 
also in brain. Thus, we tested whether the enhancement 
of stem and progenitor proliferation and tissue 
maintenance by hESC-secreted proteins is conserved 
between muscle and brain. The brain undergoes many 
changes with aging, including neuronal cell death, 
thinning of the cortex and loss of brain plasticity, and 
the accumulation of plaques and neurofibrillary tangles 
[16-19]. Additionally, two regions of the adult brain – 
the dentate gyrus of the hippocampus and the 
subventricular zone of the forebrain – harbor neural 
stem cells (NSCs) that express the marker Sox-2 and are 
able to give rise to neurons and glia in vivo and in 
culture. During the natural aging process, similarly to 
muscle function, cognitive function declines, which 
may be in part due to the diminished ability of the 
neural stem cells in the subgranular zone of the dentate 
gyrus to proliferate and give rise to new neurons [2, 3].   
 
In addition to decrease in neurogenesis observed with 
aging, the central nervous system can suffer from a 
number of age-associated neurodegenerative disorders. 
We have developed an in vitro Alzheimer's disease 
model in which hESC-derived cortical neurons are 
exposed to a very toxic form of Amyloid beta (Aβ) 
(Vazin et al., submitted), soluble oligomeric forms of 
Aβ known as “globulomers”, which have shown a 
stronger clinical correlation with the cognitive deficit 
than the overall plaque load [20, 21].  Exposure of 
hESC-derived glutamatergic neurons to such Aβ 
oligomers induces signs of the disease, including age-
dependent binding of Aβ and cell death. 
 
In investigating the pro-myogenic properties of hESC-
secreted proteins, we explored a hypothesis that key 
factors may contain heparin-binding domains, as many 
proteins known to be key mitogenic regulators of cell-
fate specification and secreted by embryonic cells bind 
heparin or act in complex with heparin-bound proteins 
[22, 23]. Consistent with this hypothesis, we establish 
that that depletion of the heparin-binding proteins 
abrogates, while the enrichment for these proteins 
robustly manifests, the pro-regenerative activity of the 
hESC-conditioned medium. In addition to providing a 
novel method for enrichment of the therapeutic factors 
that are secreted by the hESCs, this study demonstrates 
the positive effect of these molecules on tissue 
regeneration and maintenance not only in muscle, but 
also in brain. Namely, hESC-secreted proteins robustly 
enhanced the proliferation of adult NSCs, suggesting a 
promising application for both the enhancement of 
cognitive function and improved outcome of NPCs 
transplantation; and notably, proteins secreted by 
hESCs had significant neuroprotective, anti-apoptotic 
effect on human cortical neurons exposed to αβ, 
demonstrating a potential novel therapy for combating 
AD.  Importantly, f this work establishes that hESC-
secreted proteins act independently of recombinant 
FGF-2 that is contained in their growth medium. 
Interestingly, we also show that mTeSR-1 hESC-
conditioned medium exhibits potent pro-myogenic 
properties due to the high levels of FGF-2.  In FGF-2 is 
not a pro-aging molecule, our work demonstrates that 
FGF-2 does not signal in the aged muscle stem cells and 
uncovers an interesting, age-specific mis-localization of 
the FGF-2 ligand, which may reflect a fundamental 
difference not only in the permissiveness of FGF-2 
signaling in young vs. old muscle, but also in the ability 
of old differentiated muscle cells to secrete this 
mitogen.  
 
RESULTS AND DISCUSSION 
 
mTeSR-1 growth medium has pro-myogenic activity, 
which is due to the high levels of FGF-2, and hESC-
secreted factors act independently of recombinant 
FGF-2 
 
Our previous work established that injection of hESCs – 
which were cultured on mouse embryonic fibroblasts 
(MEF) and in standard, highly mitogenic, embryonic 
cell growth medium – enhanced old muscle 
regeneration [4].  In our more recent work, the hESCs 
have been cultured in mTeSR-1 (Stem Cell 
Technologies), a defined feeder-free medium which is 
also highly mitogenic [9], and we investigated whether 
and to what degree the pro-myogenic effects of hESC-
conditioned medium was due to the residual activity of 
the hESC growth/expansion medium.  Primary muscle 
progenitor cells (myoblasts) were cultured overnight in 
a mitogen-low fusion medium that typically induces 
differentiation of myoblasts into multinucleated 
eMyHC+ myotubes. The enhancement of myogenic cell 
proliferation and inhibition of differentiation was assayed 
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Figure 1. Both mTeSR‐1 and hESC‐Conditioned mTeSR‐1  increase primary myoblast and satellite cell Proliferation and
inhibit Differentiation. (A) Primary Mouse Myoblasts were cultured for 24 hours in 50% fusion/differentiation medium (DMEM, 2%
horse serum) plus 50% of the specified medium.   A 2 hour BrdU pulse was performed before cell fixation to  label proliferating cells.
Immunofluorescence was performed for eMyHC (green) and BrdU (red), with Hoechst (blue) labeling all nuclei. Representative images
are shown. Proliferation and differentiation of fusion‐competent myoblasts were quantified by cell scoring in 25 random fields of each
condition  using  a Molecular  Devices  automated  imager  and MetaXpress  cell  scoring  software.  Results  are  displayed  as  the mean
percent of BrdU+  (B) or eMyHC+  (C) proliferating or differentiating cells +/‐SD, respectively. N=4 *P< 4X10‐10    for BrdU+ myoblasts  ‐
incubated  in  50%  mTeSR‐1  as  compared  to  myoblasts  incubated  in  just  fusion  medium,  or  50%    hESC‐conditioned  mTeSR‐1  as
compared to myoblasts incubated in just fusion medium. *P< 0.005 for eMyHC+ fusing myoblasts in 50% mTeSR‐1 as compared to myo‐
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by BrdU uptake for the last 2 hours of culture, after 
which cells were fixed and used for immuno-
fluorescence with anti-BrdU and anti-MyHC specific 
antibodies. When primary myoblasts were cultured in 
50% fusion medium plus 50% hESC-conditioned 
mTeSR-1 or 50% unconditioned mTeSR-1, both media 
compositions induced proliferation and inhibited 
differentiation of these myogenic cells, though medium 
containing hESC-conditioned mTeSR-1 inhibited 
differentiation more significantly (Figure 1A, quantified 
in B and C). To confirm these data with muscle stem 
cells, injury-activated satellite cells associated with 
myofibers were isolated from old muscle and cultured 
overnight in a 50/50 mix of Opti-MEM containing 5% 
old mouse serum and hESC-conditioned mTeSR-1 or 
mTeSR-1. Both conditioned and not-conditioned 
mTeSR-1 media enhanced the regenerative capacity of 
satellite cells that were isolated from injured old 
muscle, based on the numbers of de-novo generated 
BrdU+/Desmin+ muscle progenitor cells (Figure 1D, 
quantified in E). These results demonstrate that 
embryonic stem cell culture medium itself has pro-
myogenic effects.  To investigate whether hESC-
conditioned Opti-MEM exhibits pro-regenerative 
effects due to the hESC-secreted proteins, and not 
because of residual mTeSR-1, we washed the hESC 
culture wells multiple times with Opti-MEM prior to 
incubation for conditioning the Opti-MEM, and found 
that even after 3 washes, hESC conditioned the Opti-
MEM to yield the same potent pro-regenerative effect 
on myoblasts (Figure 1F).  These results demonstrate 
that while mTeSR-1 supplementation promotes 
myoblast proliferation, other factor(s) produced by 
hESCs independently enhance the regenerative capacity 
of muscle stem and progenitor cells.  
 
To understand the pro-myogenic effects of mTeSR-1 in 
greater detail, we addressed the role of FGF-2,  which is  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
present at high concentration in mTeSR-1 (over 50 
nanograms per milliliter, ~10 times higher than the 
doses used in conventional culture of muscle progenitor 
cells). Our hypothesis was that the FGF-2 in mTeSR-1 
enhances myoblast and satellite cell proliferation, 
partially masking the effects of the hESC-produced 
factors in hESC-conditioned mTeSR-1. To test this 
hypothesis, we incubated hESCs in a basal medium that 
had the other growth and signaling factors present in 
mTeSR-1 (TGF-beta, GABA, pipecolic acid and 
Lithium Chloride, [9]), but lacked FGF2, and compared 
the pro-myogenic effects of this FGF-free hESC-
conditioned mTeSR-1 analog with the effects of the 
same mTeSR-1 analog that was not conditioned by the 
hESCs. Without FGF-2, the mTeSR-1 analog lacked 
pro-regenerative effects on myoblasts (Figure 2A, 
quantified in 2B). On the other hand the very same 
mTeSR-1 analog lacking FGF-2, but conditioned by 
hESCs, significantly enhanced myoblast proliferation 
and inhibited differentiation, while conditioning of this 
mTeSR-1 analog lacking FGF-2 by differentiated hESC 
derived cells resulted in the absence of pro-myogenic 
properties (Figure 2A, quantified in 2B). These data 
demonstrate that the pro-myogenic effects of mTeSR-1 
are due to the high concentration of FGF-2, and that it is 
not simply residual FGF-2 from mTeSR-1 that is 
responsible for the enhancement of myogenesis by the 
hESC-conditioned medium. 
 
FGF-2 signaling and satellite cell proliferation are 
not increased with age 
 
FGF-2, which often functions as a mitogen, was 
recently reported to contribute to the aging and 
depletion of mouse satellite cells.  However, the 
canonical model of muscle stem cell aging postulates 
that a decline in such mitogens over time leads to 
reduced activation of satellite cells that are resident to 
blasts incubated in fusion medium alone, and  *P< 9X10‐5  for eMyHC+ fusing myoblasts in 50% hESC‐conditioned mTeSR‐1 as compared
to myoblasts incubated in just fusion medium. (D) Old injury activated myofiber‐associated satellite cells were isolated at 3 days post
cardiotoxin‐induced muscle injury, and cultured  overnight in 50% DMEM/F12 with 10% old serum, and 50% of the medium specified,
followed  by  a  2  hour  BrdU  pulse  to  label  proliferating  cells  before  cell  fixation.  Immunofluorescence was  performed with Desmin
(green) and BrdU (red), with Hoechst (blue) labeling all cell nuclei. Representative images are shown and demonstrate that both hESC‐
conditioned mTeSR‐1 and mTeSR‐1 have a pro‐myogenic effect on activated  satellite  cells.  (E) Proliferating Desmin+/BrdU+  satellite
cells  were  quantified  by  cell  scoring  in  multiple  random  fields  of  each  condition.  Results  are  displayed  as  the  mean  percent  of
BrdU+/Desmin+ proliferating satellite cell cells +/‐SD. N=3, *P< 0.05  for satellite cells  in 50% mTeSR‐1 as compared  to satellite cells
incubated  in  just basal medium with old serum, and *P< 0.001    for satellite cells  in 50% hESC‐conditioned mTeSR‐1 as compared  to
satellite cells  incubated  in  just basal medium with old serum.  (F) Undifferentiated hESCs that were grown  in mTeSR‐1 medium were
washed 0‐3 times with Opti‐MEM, followed by overnight  incubation  in Opti‐MEM and collection of the resulting conditioned Opti‐MEM.
The hESC‐conditioned Opti‐MEM was spun down to remove cell debris, before addition to myoblasts as a 50/50 mix with  myogenic fusion
medium for culture overnight.  A 2 hour BrdU pulse was performed to label proliferating cells prior to cell fixation and immunofluorescence
was performed with eMyHC and BrdU, with Hoechst labeling all cell nuclei (images not shown). Proliferating and differentiating cells were
quantified by cell scoring 25 random fields of each condition using an automated imager and MetaXpress cell scoring software. Results are
displayed as the mean percent of BrdU+ or eMyHC+ proliferating or differentiating cells +/‐SD, respectively.  N=2  
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old tissue [1, 24, 25], so we explored these phenomena 
in more detail.  The levels of FGF-2 were determined 
by Western Blotting in muscle fibers that were derived 
from Tibialis Anterior (TA) and Gastrocnemius 
(Gastroc) muscle of young and old mice.  As shown in 
Figure 3A (quantified in 3B), a significant increase in 
FGF-2 protein was observed with age in myofibers, 
consistent with Chakkalakal et al. FGF-2 signals 
through the MAPK/pERK pathway, so we analyzed the 
levels of pERK in myofibers derived from young and 
old uninjured muscle. Interestingly, as shown in Figure 
3 A (quantified in 3B), no age-specific increase in 
pERK was found, and the levels of this key effector 
were very low in cells from both ages, despite the high 
levels of FGF-2 in protein lysates derived from old 
muscle fibers.  Also, a myoblast control indicates that 
pERK detection was sensitive (Figure 3A).  To under-
stand these data, we examined the presence and 
localization   of  FGF-2  in  the   intact  young  and   old  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
muscle, using 10 micron cryosections.  FGF-2 and 
laminin were detected with specific antibodies and 
resolved by immunofluorescence.  As shown in 
Figure 3 C (quantified in 3D), FGF-2 was localized in 
the basement membrane of young muscle, while in 
the old muscle, FGF-2 was present less in the 
basement membrane and more in the cytoplasm of the 
myofibers (e.g. away from its receptors in muscle 
stem cells).  These data suggest that the relatively 
higher levels of FGF-2 in old muscle do not 
necessarily represent ligand that is available for 
signaling in satellite cells. Additionally, these results 
indicate that detection of elevated FGF-2 in the old 
muscle might be due to its over-expression within the 
old muscle fiber itself, or alternatively, due to 
“washing” of extracellular FGF-2 from young muscle 
during tissue dissociation when the basement 
membrane is digested with collagenase and dispase, 
and tissue integrity is perturbed [26]. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2. hESC‐conditioned medium enhances myogenic proliferation in the absence of FGF2 in mTeSR‐1 growth
medium.  (A)  Primary myoblasts were  cultured  for  16  hours  in  50%  fusion/differentiation Medium  +  50%  of  the  specified
medium.  A  2  hour  BrdU  pulse  was  performed  before  cell  fixation  to  label  proliferating  cells.  Immunofluorescence  was
performed for eMyHC (green) and BrdU (red), with Hoechst (blue) labeling all nuclei. Representative images demonstrate that
hESC‐conditioned  medium  lacking  FGF2  increases  myoblast  proliferation  and  inhibits  differentiation.  (B)  Proliferation  and
differentiation of  fusion‐competent myoblasts were quantified by cell scoring  in 50 random  fields of each condition using an
automated  imager  and MetaXpress  cell  scoring  software.  Results  are  displayed  as  the mean  percent  of  BrdU+  or  eMyHC+
proliferating or differentiating cells +/‐SD, respectively. N=4, *P< 2X10‐12  for hESC‐conditioned basal medium with 4 mTeSR‐1
ingredient  components  (lacking  FGF2)  as  compared  to  differentiation  hESC‐conditioned  basal  medium  with  4  mTeSR‐1
ingredient components  (also  lacking FGF2), and  for hESC‐conditioned basal medium with 4 mTeSR‐1  ingredient components
(lacking FGF2) as compared to myoblasts incubated in basal medium with 4 mTeSR‐1 ingredient components (lacking FGF2).  
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To confirm and extend upon these findings, we isolated 
muscle stem cells from uninjured young and old TA and 
Gastroc muscle and treated them with FGF-2 for 30 
minutes, after which the levels of FGF-2, pERK, and 
total ERK were determined in these freshly isolated 
stem cells. As shown in Figure 4 A, B, endogenous 
FGF-2 was undetectable in either young or old muscle 
stem cells upon isolation, but the added FGF-2 was 
clearly present in these satellite cells after 30 minutes.  
Young and old satellite cells were harvested after just 
30 minutes of culture, thus, the FGF-2 protein detected 
in cultures, which were treated with recombinant FGF-2 
is unlikely to represent de-novo expression. Satellite 
cells were lifted from the plates with PBS and washed 
prior to their lysing for Western Blotting, and it was 
thus unlikely that any residual, non-cell associated 
recombinant FGF-2 from  media  or  plates  would  con- 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
taminate cell lysates.  To test this directly and 
definitively, we performed a control with a matrix-
coated but cell-free plate that was identically treated 
with FGF-2, and found no detectable recombinant FGF-
2 in the solution (Figure 4A). Hence, the FGF-2 
detected in protein lysates of young and old satellite 
cells incubated with this growth factor likely reflects 
ligand that is bound to its specific receptors.  In support 
of this conclusion, recombinant FGF-2 induced pERK 
in both young and old satellite cells (Figure 4 A and C). 
In agreement with non-detectable endogenous FGF-2 in 
both young and old satellite cells, very low levels of 
pERK that did not differ with age were observed in 
these muscle stem cells resident to tissue that was 
neither injured nor treated with recombinant FGF-2 
(Figure 4 A and C).  To determine whether low levels 
(as opposed to none) of FGF-2 can be detected in the 
Figure 3. Age‐dependent comparison of FGF2 and pERK levels and localization in muscle fibers. (A) Protein was
isolated from freshly‐derived uninjured myofibers of young and old mice and the levels of FGF2 and phospho‐ERK1/2; total
ERK1/2 and cytoplasmic beta‐actin were analyzed by Western blotting, using specific antibodies. Representative data are
shown. (B) Relative protein expression was quantified in 3 young and 3 old mice by normalization of FGF‐2 to beta‐actin and
normalization of pERK to total ERK; significantly higher levels of FGF‐2, but not of pERK were detected in the old myofibers,
as compared to young (n=3, * P<0.05). (C) Tibialis anterior (TA) muscle from 2 young and 2 old mice were sectioned and
immunostained for laminin (green) and FGF2 (red). Hoechst (blue) labels all nuclei. Representative images demonstrate the
presence of FGF‐2 and laminin  in muscle compartments, as compared to the negative IgG control and higher FGF‐2 levels
seem  to  be  present  in  the  laminin+  basement membranes  of  the  young myofibers,  as  compared  to  old.  (D).  The  pixel
density  of  FGF‐2  that  co‐localizes  with  laminin+  basement  membrane  vs.  the  internal  regions  of  the  myofibers  was
determined in 30‐40 areas of each cryosection of 3 muscle tissue slides from young and old muscle, using Image J software.
Preferential localization of FGF‐2 in the basement membrane was identified in young muscle, while in the old tissue, FGF‐2
was mis‐localized to the center of the myofibers and away from the basement membrane, n=3, * P<0.05.  
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muscle stem cells, another independent experiment was 
performed with a prolonged enhanced chemilumines-
cence exposure of the Western Blots. As shown in 
Supplementary Figure 1, low levels of FGF-2 could be 
indeed detected in muscle  stem cells after  a  30  minute  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
exposure, but once again, there was no age-specific 
difference in either FGF-2 or in pERK. These results 
suggest that FGF-2 does not signal in either young or 
old satellite cells that reside in non-injured skeletal 
muscle. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4. Age‐related comparison of FGF2 and pERK levels in muscle stem cells derived from uninjured
tissue and of proliferation of these cells.  (A) Quiescent muscle stem cells were isolated from uninjured young
and old muscle as described in Methods. The cells were treated (or not) with FGF2 (10ng/ml) for 30 minutes before
being lysed and analyzed for the levels of FGF2, phospho‐ERK1/2, total ERK1/2 and beta actin by Western Blotting.
Representative  images are  shown.  (B) Relative protein expression of FGF‐2, pERK and  total ERK were quantified
from 3 young and 3 old mice, using beta‐actin for normalization. The levels of FGF‐2 were equally undetectable in
young  and  old  satellite  cells,  however,  added  FGF‐2 was  clearly  detected  in  the  cells  of  both  ages  after  ~2min
exposure (but was not detected in accelular samples even after 10min exposure); the levels of pERK and total were
equally low in young and old satellite cells and pERK, but not total ERK was, as expected, induced by added FGF‐2.
n=3, * P<0.05.  (C) Muscle stem cells  from resting muscle were treated  (or not) with FGF2  (10ng/ml)  for 24 hours
before immunostaining for Ki67 and Pax7. Percent of Ki67+/Pax7+ proliferating myogenic cells were quantified. No
age‐specific  increase  in cell proliferation was detected  in satellite cells  isolated from old uninjured muscle, and  in
contrast, more proliferating satellite cells were observed  in the cultures derived from young muscle. Added FGF‐2
enhanced the proliferation of both young and old muscle stem cells in these overnight cultures. n=3, * P<0.05.  
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To directly examine cell proliferation, satellite cells 
were isolated from non-injured young and old tissue and 
were cultured with or without FGF-2 overnight, after 
which the levels of the proliferation marker Ki67 were 
determined in Pax7+ satellite cells. Muscle stem cells 
for this and other experiments were isolated with high 
and equal purity from young and old mice, as shown in 
Supplementary Figure 2. Neither young nor old cells 
were lost during overnight culturing, as the numbers 
were similar to initial plating, and no age-specific loss 
was observed, based on the cell counts. As shown in 
Figure 4 D and E, no increase in proliferation of aged 
muscle stem cells was detected, as compared to young, 
and as expected from previous literature, the majority of 
both young and old satellite cells were quiescent [14, 
26, 27]. When added, FGF-2 significantly enhanced the 
proliferation of quiescent muscle stem cells that were 
isolated from uninjured muscle (both young and old), as 
shown in Figure 4 D and E, which is consistent with the 
induction of pERK that is shown in Figure 4 A, C. 
However, very interestingly, 90-95% of muscle stem 
cells derived from uninjured young and old tissue were 
not proliferating even in the presence of added FGF-2, 
suggesting that other mitogens and / or cell-fate changes 
are needed to induce the robust entry of quiescent 
satellite cells into the cell cycle, also as published [13]. 
These data demonstrate that the localization of FGF-2 
within the skeletal muscle compartment changes with 
age and question whether endogenous FGF-2 is likely to 
exhaust the pool of aged quiescent satellite cells, since it 
does not induce significant signaling in these cells. 
 
The pro-regenerative activity of hESC-secreted 
factors is contained in proteins with heparin binding 
domains 
 
Based on the fact that many growth factors that are 
known to enhance cell proliferation contain heparin 
binding domains, or act by association with heparin 
binding proteins as co-activators of signal transduction 
[22, 23], we hypothesized that hESC-secreted factors 
that have pro-regenerative activity may be proteins that 
might bind heparin, and furthermore postulated that 
hESC-conditioned medium depleted of heparin-binding 
proteins would lose the ability to enhance myoblast 
proliferation.  To confirm that the factors in hESC 
conditioned medium were proteins, hESC conditioned 
Opti-MEM was treated with proteinase-K agarose 
beads, and the beads were removed before mixing 50/50 
with Opti-MEM and 5% mouse serum, for culture with 
injury-activated satellite cells with associated fibers 
from old muscle, as above.  All proliferative activity of 
the conditioned medium was lost after proteinase 
treatment, indicating that protein(s) conferred the pro-
regenerative activity (Supplemental Figure 3). 
To deplete heparin-binding proteins, hESC-conditioned 
medium was incubated with heparin binding domain - 
coated acrylic beads. Muscle progenitor cells were then 
cultured in this heparin-depleted hESC-conditioned 
medium, hESC-conditioned medium, or controls 
(medium alone and medium conditioned by 
differentiated cells that lack the pro-regenerative 
activity). Proliferation of primary muscle progenitor 
cells was assayed by BrdU uptake for 2 hours, and cell 
differentiation was assayed by the expression of 
eMyHC. Interestingly, hESC-conditioned medium 
depleted of heparin binding proteins completely lost its 
pro-regenerative activity on muscle progenitor cells 
(Figure 5 A, quantified in B).  Even more importantly, 
the pro-regenerative activity of in the hESC-secreted 
proteins could be eluted from the heparin-coated beads 
(Figure 5 A, quantified in B), hence confirming that 
these factors have heparin-binding domains and 
suggesting novel strategies for purification of these 
clinically relevant molecules. Excitingly, when these 
heparin-binding eluted embryonic proteins were 
injected at Day 0 and Day 2 into injured muscle (e.g., at 
the time of the injury and when muscle stem cells 
become activated for regeneration) old muscle repair 
became rejuvenated, based on increased formation of 
de-novo myofibers with centrally located BrdU+ nuclei 
(Figure 5C, quantified in D). These data reveal the pro-
myogenic proteins that are secreted by the hESCs 
contain heparin-binding domains. 
 
hESC-conditioned Opti-MEM has Pro-Survival and 
Pro-Mitogenic effects on Neuronal Cell Types 
 
To assess the potential positive effect of hESC-secreted 
proteins on other cell types, specifically neural cells, we 
cultured rat neural progenitor cells in the presence of 
hESC-conditioned medium, or in a control medium 
conditioned by differentiated hESC-derived cells. 
Specifically, cells were cultured in the 50/50 mix of 
neural differentiation medium (see Methods) and Opti-
MEM, which was conditioned either by the self-renewing 
hESCs or by the negative control, differentiated hESC-
derived cells. The goal was to determine if hESC-
secreted factors can enhance proliferation and inhibit 
differentiation of NPCs, in parallel to our studies 
demonstrating these embryonic factors enhance muscle 
precursor proliferation and inhibit their differentiation in 
a 50/50 mix of fusion medium [5]. Very interestingly, a 
significant increase in proliferation of Sox-2+ neural 
progenitors was observed in cultures exposed to the 
hESC-produced proteins, an effect that was lost when 
NPCs were cultured in control medium from differentiat-
ed cells (Figure 6 A, quantified in B). As this effect was 
similar to what we previously reported for muscle 
stem/progenitor cells, in that we observe an enhancement 
  
www.impactaging.com                    364                                            AGING, May 2013, Vol. 5 No.5
of proliferation and inhibition of differentiation of 
precursor cells by hESC-secreted factors [5], it suggests 
that  hESC-secreted   proteins  enhance  the   proliferative  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
capacity of progenitor cells in multiple tissue types, and 
similarly to the situation in muscle, the pro-mitogenic 
activity is lost when hESCs differentiate.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 Old Tibialis Anterior muscles were injured with cardiotoxin (see Methods). Heparin bound and eluted protein or vehicle control
(Opti‐MEM) were injected into sites of injury on Day 0 and Day 2. BrdU was injected (intraperitoneal) at 3 days post injury to
label  proliferating,  fusion‐competent  myoblasts.    Animals  were  sacrificed  and  muscle  was  collected  5  days  post  injury.
Cryosections  (10 µm) were analyzed by hematoxylin/eosin  (H&E)  staining and  immunostaining  for embryonic myosin heavy
chain  (eMyHC,  shown  in  green)  and  BrdU  incorporation  (shown  in  red).    Hoechst  stains  nuclei  (blue).  As  shown  by
representative images, the regenerative outcome of old muscle given eluted factors was significantly improved as compared to
old muscle given Opti‐MEM vehicle control, based on significantly diminished scar tissue formation, larger and more dense de
novo myofibers and an  increase  in  the numbers of eMyHC+ myofibers with centrally‐located BrdU+ nuclei  that  replaced  the
damaged tissue. (D) Regeneration of old mouse Tibialis Anterior 5 days post injury, that received eluted factors or vehicle, was
quantified  from muscle  sections, and  is presented as  the number of newly  regenerated myofibers per  square millimeter of
injury site. Error bars indicate SD, n=3 mice per group. *P <0.02 between old given eluted factors and old given vehicle control. 
Figure  5.  Pro‐regenerative  Embryonic  Factors
Contain  Heparin  Binding  Domains.  (A)  Primary 
Mouse Myoblasts were  cultured  for  24  hours  in  50% 
fusion/differentiation medium  +  50%  of  the  specified 
medium.   A 2 hour BrdU pulse was performed before 
cell  fixation  to  label  proliferating  cells.  Immuno‐
fluorescence  was  performed  for  eMyHC  (green)  and 
BrdU  (red),  with  Hoechst  (blue)  labeling  all  nuclei. 
Representative images are shown. (B) Proliferation and 
differentiation  of  fusion‐competent  myoblasts  were 
quantified  by  cell  scoring  in  25‐100  random  fields  of 
each  condition  using  an  automated  imager  and 
MetaXpress cell scoring software. Results are displayed 
as the mean percent of BrdU+ or eMyHC+ proliferating 
or  differentiating  cells  +/‐SD,  respectively.  N=6  *P< 
3X10^‐45  for hESC‐conditioned Opti‐MEM  compared  to 
differentiated  hESC‐conditioned Opti‐MEM,  and  hESC‐
conditioned  Opti‐MEM  compared  to  Opti‐MEM. 
*P<0.005 for hESC‐conditioned Opti‐MEM compared to 
heparin  depleted  hESC‐conditioned  Opti‐MEM,  and 
hESC‐conditioned  Opti‐MEM  compared  to 
differentiated hESC‐conditioned OptiMEM. *P< 5X10^‐7
for  hESC‐conditioned  Opti‐MEM  compared  to  Opti‐
MEM, and Eluted Proteins compared to Opti‐MEM.  (C) 
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Figure  6.  hESC‐secreted  Factors  Enhance  NPC  Proliferation  and  are  Neuroprotective.  (A)  Rat  Neural  Progenitor  Cells
(rNPCs) were cultured overnight in 50% differentiation medium (DMF12 + N2) and 50% specified medium followed by a 4 hour BrdU
pulse to label proliferating cells prior to fixation. Immunofluorescence was performed for Sox2 (red) and BrdU (green), with Hoechst
(blue) labeling cell nuclei.  Representative images are shown. (B) Quantification of BrdU+/Sox2+ proliferating cells was performed by
cell  scoring  in 100  random  fields of each condition using an automated  imager and MetaXpress cell  scoring  software. Results are
displayed as the mean percent of BrdU+/Sox2+ proliferating cells +/‐SD; N=4, *P< 2X10‐15 for rNPCs  incubated  in hESC‐conditioned
Opti‐MEM as compared  to  rNPCs  incubated  in differentiated hESC‐conditioned Opti‐MEM, and *P< 0.0002  for  rNPCs  incubated  in
hESC‐conditioned  Opti‐MEM  as  compared  to  rNPCs  incubated  in  Opti‐MEM.  (C)  Pre‐incubation  of  Aβ  globulomers with  hESC  –
conditioned Opti‐MEM before incubation with mature cortical neurons prevents neuron cell death and exhibits a neurotrophic effect,
as shown via decreased    immunofluorescence staining of cleaved caspase3  (red)   and  increased Map2 +  (green) neurons. Hoechst
(blue)  labels all nuclei. Representative  images are  shown.  (D) Total number of Map2+ neurons and  the amount of apoptosis was
quantified  by  cell  scoring  of  random  fields  taken  by  an  automated  imager  of  each  condition  in  the  above  assay  performed  in
replicates.  Results  are  displayed  as  the  mean  percent  of  caspase  +  or  Map2+  (C)  proliferating  or  differentiating  cells  +/‐SD,
respectively. N=4, *P< 0.02 for Map2+ cortical neurons treated with Aβ globulomers preincubated in hESC‐conditioned Opti‐MEM, as
compared to treatment with Aβ globulomers in OptiMEM, and *P< 0.05 for the level of caspase3 in cortical neurons treated with Aβ
globulomers preincubated in hESC‐conditioned Opti‐MEM, as compared to treatment with Aβ globulomers in Opti‐MEM.  
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We next sought to examine whether not only cell 
proliferation, but cell viability might be enhanced by the 
hESC-secreted proteins, particularly under pathological 
conditions.  Likewise, we wished to investigate whether 
the effects of the pro-mitogenic factors would manifest 
not only on progenitors, but also on terminally 
differentiated neurons. To answer these questions, we 
generated human cortical glutamatergic neurons by 
directed differentiation of embryonic stem cells (see 
Methods). Specifically, dorsal telencephalic progenitors 
expressing glutamate and VgluT1 were generated by 
using Shh and FGF-2. This protocol induced the 
differentiation of human embryonic stem cells (hESCs) 
into cultures with up to 74% of neurons expressing 
glutamate and VgluT1.  As an in vitro model of AD, 
soluble oligomeric forms of Aβ known as “globule-
mers,” which have been implicated in the pathology of 
Alzheimer's disease [20, 21], were added to these 
cultures of human glutamatergic neurons. They bound 
Aβ, which led to cell death as measured by the presence 
of cleaved caspase 3 (Figure 6C, quantified in D).  
 
To examine whether hESC-secreted factors have 
neuroprotective effects in this in vitro human AD 
model, Aβ globulomers were added to cortical cultures 
primarily comprised of glutamatergic neurons in the 
presence or absence of hESC-conditioned medium.  
The neurons were pre-incubated with hESC-
conditioned Opti-MEM for 1 hr prior to treatment with 
Aβ globulomers, or alternatively, hESC-conditioned 
medium was added at 50% to neuron medium, 
simultaneously with the Aβ globulomers.  Analysis 
with cleaved caspase-3 as an apoptotic marker and 
MAP2 as neuron marker showed a significant decrease 
in cell death when neurons were pre-incubated with 
hESC-secreted factors, as compared to cultures treated 
with Aβ globulomers alone (Figure 6 C, quantified in 
D).  A noticeable but not statistically significant 
decrease of apoptosis was observed in neuron cultures 
that were administered with Aβ and hESC-secreted 
proteins simultaneously (Figure 6 C, D).  These data 
suggest that hESC-secreted factors exert a protective 
(anti-apoptotic) effect on human cortical neurons in 
this AD model. 
 
Conclusions 
 
Since the comprehensive molecular identity of the 
specific proteins that are responsible for the pro-
regenerative effects of the hESC-conditioned medium is 
a work in progress, we report here the ability to enrich 
these proteins using the heparin binding domains, and 
thus to provide a novel approach to study these 
clinically relevant molecules. Our ability to enrich the 
pro-regenerative activity of the hESC-secreted proteins 
is particularly important, because these embryonic 
factors improved the regenerative capacity of not only 
muscle, but also enhanced proliferation of neural 
progenitor cells, suggesting their possible ability to 
combat tissue degenerative disorders in multiple organ 
systems. Furthermore, hESC-secreted proteins exhibited 
not only proliferative effects on different progenitor cell 
types, but also neuroprotective effects on human 
cortical neurons in an in vitro model of Alzheimer's 
disease. These results suggests that hESC-produced 
molecules either prevent the death of human cortical 
neurons in an Aβ induced neurotoxic environment or 
are able to reduce the effect of Aβ toxicity by 
preventing the interaction of such toxic species with 
neuronal phenotypes that highly susceptible to Aβ, both 
possibilities that are clinically relevant outcomes and 
would be very interesting to study further. 
 
With respect to the enhancement of myogenesis, this 
work revealed a pro-myogenic effect of mTeSR-1, 
which was linked to the high levels of FGF-2, a known 
inducer of   proliferation in multiple cell types. 
Importantly, we show that the pro-myogenic activity of 
the hESC-secreted proteins manifests without added 
FGF-2 and that the hESC-conditioned Opti-MEM, 
which we typically use, does not contain any residual 
activity that is derived from mTeSR1. 
 
While we found that the levels of FGF-2 protein are 
indeed elevated in old myofibers (in agreement with 
Chakkalakal et al.), signaling downstream of FGF 
signaling, namely pERK, was low and not different 
between the young and aged muscle stem cells or 
muscle fibers. In resolution of this interesting 
conundrum, we found that while in the old muscle this 
protein is localized intracellularly within the myofibers 
(away from its receptors and from satellite cells), in the 
young muscle, FGF-2 is located mostly extracellularly 
in the basement membrane, which is the niche of 
muscle stem cells. As such, this work suggests that 
much more FGF-2 ligand is available for signaling to 
young muscle stem cells than in old muscle, but it is 
still unclear why FGF-2 does not induce proliferation of 
quiescent satellite cells in uninjured young muscle. 
Potentially, the disruption of the basement membrane 
due to the injury or attrition of the myofibers, 
differentiation of satellite cells along myogenic lineage, 
and/or extracellular matrix – based activation of FGF-2 
for binding to its receptors might be required for the 
induction of FGF-2 signaling in the muscle stem cells 
responding to tissue damage.  In support of this 
conclusion, FGF-2 had a weak effect on the 
proliferation of quiescent muscle stem cells derived 
from non-injured mice (both, young and old); and thus, 
not FGF-2 alone but other factors and signaling 
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pathways are likely required for the breakage of satellite 
cell quiescence [5].  In support of this model, the MM14 
myoblast line was found to be responsive to exogenous 
FGF-2 ligand, but not endogenous, and ectopic 
expression of oncogenic ras was found to be required to 
liberate or activate the endogenous extracellular FGF-2 
for signaling [28].  Low numbers (~3-4%) of 
proliferating Ki67+ young satellite cells are explained 
by the fact that these cells (expected to be 99.1% 
quiescent) were cultured overnight in their own young 
serum that is known to be pro-proliferative [29]; 
proliferation of the aged quiescent satellite cells derived 
from uninjured muscle and cultured with old serum was 
very low, which is consistent with the fact that old 
satellite cells divide very poorly in the presence of aged 
serum [14, 30-32].  
 
FGF-2 does not have a signal peptide, and the 
mechanisms of FGF-2 activation are not well described 
in general or in skeletal muscle [26, 29]; therefore, 
further work is required to understand the age-
dependent defect in the localization and activation of 
FGF-2 signal transduction in muscle stem and 
progenitor cells. Notably, differential localization of 
FGF-2 might introduce experimental artifacts into its 
detection, since the basement membranes of myofibers 
typically become digested during muscle dissociation, 
and the plasma membrane may be damaged [26, 29]; 
thus, the identification of the precise levels of FGF-2 in 
sub-cellular compartments of skeletal muscle is not an 
easy task. 
 
Importantly, our data directly demonstrate that the 
numbers of proliferating (Ki67+Pax7+) muscle stem 
cells do not increase with age, which is further 
corroborated by the lack of age-specific increase of 
BrdU+ muscle stem cells after 4-6 weeks of in vivo 
delivery of BrdU to young and old mice (Amy 
Wagers, personal communications). Summarily, it is 
inconsistent with our data that FGF-2 promotes 
proliferation of quiescent muscle stem cells in old 
mice, though it still may be possible that old satellite 
cells are lost through an indirect and MAPK-
independent activity of FGF-2. 
 
As well established, in response to injury or attrition of 
myofibers, quiescent muscle stem cells activate to 
divide, form myogenic lineage, and regenerate the 
tissue; and this process becomes inefficient with age. 
The work presented here introduces novel strategies for 
the purification and clinical use of the proteins that are 
able to rejuvenate the aged niches of organ stem cells 
and uncovers that the viability of differentiated cells in 
pathological tissues might be also enhanced by these 
clinically-relevant molecules. 
METHODS 
 
Animals. Young (2-3 month old) and old (22-24 month 
old) C57BL6/J mice were purchased from the Jackson 
Laboratory and the NIH. The animal experimental 
procedures were performed in accordance with the 
Guide for Care and Use of Laboratory Animals of the 
National Institutes of Health, and approved by the 
Office of Laboratory Animal Care, UC Berkeley.  
 
Antibodies. Antibodies for phospho-ERK1/2, ERK1/2, 
and cleaved caspase 3 were purchased from Cell 
Signaling. Laminin and Actin antibodies were from 
Sigma. FGF2 antibody was from Santa Cruz, Pax7 and 
eMyHC antibodies were from Hybridoma Bank, BrdU 
was from Abcam, and Map2 antibody was from BD 
Biosciences.  
 
Muscle fibers and muscle stem cell isolation. Uninjured 
TA muscle was dissected from healthy young and old 
mice and incubated at 37C in digestion medium (250 
U/mL Collagenase type II in DMEM medium, buffered 
with 30 mM HEPES) for 1 hour [26]. Digested muscle 
was gently triturated and myofibers were collected. 
Myofibers were further digested with 1 U/mL Dispase 
and 40 U/mL Collagenase type II to liberate muscle 
stem cells [29]. Muscle stem cells were cultured in 
DMEM with serum from the same age mouse.  
 
Immunofluorescence analysis. Cells were fixed with 4% 
PFA for 10 minutes before permeablization with 0.1% 
Triton-X 100 for 30 minutes. Then cells were then 
immunostained for Pax7 (Hybridoma Bank) and ki67 
(Abcam). Primary antibodies used for staining cortical 
human neurons were: mouse anti-MAP2 (1:500, BD 
Biosciences), rabbit anti-cleaved caspase 3 (1:100, Cell 
Signaling). For muscle section immunostaining, an 
uninjured TA muscle was sectioned at 10 um and 
stained for FGF2 (Santa Cruz) and laminin (Sigma). 
 
Western blotting.  Muscle stem cells or myofibers were 
lysed in RIPA buffer containing 1X protease inhibitor 
(Roche). The protein concentration was determined by 
Bradford assay (Bio-Rad). Cell or fiber lysates were 
resuspended in 1X Laemmli buffer (Rio-rad), boiled for 
5 minutes and separated on precast TGX gels from 
Biorad. The proteins were then transferred to PVDF 
membrane (Millipore) and blotted with the desired 
antibodies.  
 
Cell Culture. Rat NPCs were cultured in DMF12 
(Gibco) with 5% N2 and 10 ng/mL FGF2, on laminin 
and polyornithine coated plates. For experimental 
conditions, cells were plated at 40,000 cells/well in 
coated 8-well chamber slides and cultured for 12-16 
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hours at 37C in 10% CO2 incubator prior to fixation 
with 70% ethanol at 4C.  Adult human myoblasts were 
cultured and expanded in human growth medium 
(Ham’s F-10 (Gibco), 10% Bovine Growth Serum 
(Hyclone), 30 ng/mL FGF2, and 1% penicillin–
streptomycin on Matrigel (BD Biosciences) coated 
plates (1:100 matrigel:PBS), at 37C and 5% CO2. For 
experimental conditions, cells were plated at 10,000 
cells/well in Matrigel coated 8-well chamber slides 
(1:100 Matrigel: PBS), and cultured for 72 hours with 
daily re-feedings at 37C in 10% CO2 incubator prior to 
fixation with 70% ethanol at 4C.  Mouse myoblasts 
were cultured and expanded in mouse growth medium: 
Ham’s F-10 (Gibco), 20% Bovine Growth Serum 
(Hyclone), 5 ng/mL FGF2 and 1% penicillin–
streptomycin on Matrigel coated plates (1:300 matrigel: 
PBS), at 37C and 5% CO2. For experimental 
conditions, cells were plated at 40,000 cells/well on 
Matrigel coated 8-well chamber slides  (1:100 matrigel: 
PBS) and cultured for 24 hours at 37C in 10% CO2 
incubator prior to fixation with 70% ethanol at 4C.  
 
Human embryonic stem cells (H9 and H7 lines), were 
cultured on diluted Matrigel (1:30), in mTeSR-1 (Stem 
Cell Technologies), according to manufacturer’s 
recommendations.  hESCs were differentiated after 
plating in mTeSR-1 by changing the medium to 
DMEM/F12 with 10% Bovine Growth Serum 
(Hyclone), and culturing for an additional 6-8 days. 
Cells were washed with Opti-MEM (Gibco) and then 
cultured in Opti-MEM for 18 hours prior to collection 
as hESC-Conditioned Opti-MEM (hESC-Conditioned 
Medium) and stored at -80C. 
 
All experiments using a MEK inhibitor were treated 
with 10 micromolar MEK1/2 Inhibitor (U0126, Cell 
Signaling Technologies). 
 
Cell culture and cortical differentiation of human 
pluripotent stem cells. The H1 (WiCell) and hESC line 
was cultured on Matrigel-coated cell culture plates (BD) 
in mTeSR-1 maintenance medium (Stem Cell 
Technologies).  In adherent conditions, hPSCs were 
seeded at a density of 5×104 cells/cm2 in growth 
medium. At 50% confluence, the medium was gradually 
changed to neural basal medium (Invitrogen) containing 
N2 and B27 (Invitrogen). SMAD signaling inhibitors 
LDN193189 (Stemgent, 1 µM) and SB432542 (Tocris 
Biosciences, 10 µM) were added from day 1 to day 7 of 
neural induction. Cyclopamine (Calbiochem, 400 
ng/ml) and FGF-2 (Peprotech, 10 ng/ml) were added 
from days 3-14 of differentiation. After 12-14 days, 
cells were mechanically passaged into poly-L-ornithine 
(Sigma Aldrich) and laminin (Invitrogen, 20µg/ml) 
coated plates and allowed to undergo maturation for 3-6 
weeks. BDNF (10 ng/ml, Peprotech) was added to 
cultures one week after initiation of neuronal 
maturation. For EB mediated neural differentiation, 
PSCs were aggregated for 4 days in ultra low-
attachment plates (Corning) and then seeded on 
Matrigel-coated plates. Cyclopamine (5 µM) and FGF-2 
(10 ng/ml) were added to the cultures the following day 
until day 12 of neural induction. At day 14, structures 
with a rosette-like morphology were mechanically 
isolated and plated on poly-L-ornithine and laminin 
coated plates and allowed to undergo neuronal 
maturation for 4 weeks. BDNF (10 ng/ml) was added to 
the cultures one week after rosette isolation. 
 
Globulomer Preparation. The A-beta42 globulomer was 
prepared as described [33, 34]. Alkaline pretreatment of 
A-beta42 and preparation of low molecular weight A-
beta by filtration protocols were used before beginning 
the globulomer preparation. After the 18-20 h 
incubation, the globulomer sample were concentrated to 
~500 M via centrifugation and dialyzed into PBS before 
centrifuging the sample at 10,000 g for 10 min to 
remove aggregates in the pellet. The supernatant was 
saved, and the absorbance was measured at 276 nm 
wavelength to measure the concentration (extinction 
coefficient = 1390 M-1 cm-1). 
 
Immunocytochemistry. For immunoflourescence 
assays, mouse myoblasts were given a 2 hour 300μM 
BrdU pulse, respectively. Cells were then permeabilized 
in PBS + 0.25% Triton X-100 and incubated with 
primary antibodies overnight at 4C in PBS +2%FBS. 
Antigen retrieval was performed via a 10 minute 4 N 
HCl treatment followed by PBS washes. Primary 
staining was performed overnight with species-specific 
monoclonal antibodies for mouse anti-embryonic 
Myosin Heavy Chain (eMyHC, hybridoma clone 1.652, 
Developmental Studies Hybridoma Bank) and Rat-
BrdU (Abcam Inc. ab6326), and desmin (Sigma-Aldrich 
DE-U-10 used at 1:300 for best discrimination of 
myogenic cells), for myoblasts and satellite progenitor 
cells, and Goat-Sox2 (Santa Cruz) for rNPCs. 
Secondary staining with fluorophore-conjugated, 
species-specific antibodies (Donkey anti-Rat-488, #712-
485-150; Donkey anti-Mouse-488, #715-485-150; 
Donkey anti-Rat-Cy3 #712-165-150; or donkey anti-
Mouse-Cy3 #715-165-150; all secondary antibodies 
from Jackson ImmunoResearch) was performed for 1 
hour at room temperature at a 1:500 dilution in PBS 
+2%FBS. Nuclei were visualized by Hoechst staining, 
and samples were analyzed at room temperature with a 
Zeiss Axio Imager A1, and imaged with an Axiocam 
MRC camera and AxioVision software. Mouse 
myoblasts were imaged at 10X and 20X magnification, 
respectively. For cell quantification, 25-50 20x images 
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per replicate were taken on the Molecular Devices 
ImageXpress Micro automated epifluorescence imager, 
followed by automated cell quantification using the 
multiwavelength cell scoring module within the 
MetaXpress analysis software.   
 
Heparin Binding of hESC-Secreted Proteins from 
hESC-Conditioned M.edium. Heparin-Agarose Type I 
Beads (H 6508, Sigma Aldrich) were washed with 
molecular grade water and preconditioned in 1mL Opti-
MEM as recommended by manufacturer. hESC-
conditioned medium was incubated with Heparin-
Agarose Beads for 2 hours shaking at 4C. Beads and all 
medium were separated by centrifugation. Myoblasts 
were treated with depleted medium after two rounds of 
centrifugation and separation of beads and medium so 
as to remove all residual beads from depleted hESC-
conditioned medium.   
 
After depleting hESC-Conditioned Opti-MEM, the 
protein bound heparin beads were washed two times for 
10 minutes at 4C in 1ml PBS + .05% Tween-20. 
Proteins were eluted twice for 15 minutes at 4C in 
400μl of elution buffer (.01M Tris-HCl pH 7.5 +1.5M 
NaCl + 0.1%BSA) to collect proteins in a total of 800μl 
of elution buffer. The proteins were purified by dialysis 
for 2 hours shaking at 4C in 500ml McCoy’s 5A 
Medium (Gibco) followed by overnight dialysis shaking 
at 4C in 200ml Opti-MEM (Gibco). The eluted heparin 
beads were re-suspended in 800μl Opti-MEM and 
stored overnight at 4C. One hour after plating, mouse 
myoblasts were treated with respective mediums for 24 
hours prior to 2 hour BrdU pulse and fixation in 70% 
ethanol.  
 
Muscle Injury. Isoflurane was used to anesthetize the 
animal during the muscle injury procedure. For bulk 
myofiber satellite cell activation, gastrocnemius 
muscles were injected with cardiotoxin 1 (Sigma) 
dissolved at 100 micrograms per milliliter in PBS, at 4 
sites of 10 microliters each for each muscle. Muscles 
were harvested 3 days later. For focal injury, to assay 
regeneration in vivo, 5 microliters of 0.5 milligram per 
milliliter CTX was injected at two sites to the middle of 
the tibialis anterior, and muscle harvested 5 days later.  
 
Tissue Immunofluorescence and Histological Analysis. 
Muscle tissue was dissected, flash frozen in OCT 
compound (Tissue Tek; Sakura ) and cryo-sectioned at 
10 micrometers, as previously described (Conboy et al., 
2003).  Cryo-sectioning was performed through the 
entire volume of muscle (typically 50–70 sections total, 
done at 200 μm intervals), thereby serially 
reconstituting the entire tissue, ex vivo.  Muscle 
sections were stained with aqueous hematoxylin and 
eosin (H&E), as per the manufacturer’s instructions 
(Sigma-Aldrich).  Regeneration and myogenic potential 
was quantified by examining injury sites from 
representative sections along the muscle (spanning the 
volume of injury), then by measuring the injured/rege- 
nerating area using Adobe Photoshop Elements.  
Myofiber regeneration was quantified by counting total 
newly regenerated fibers and dividing by the 
regeneration area. Immunostaining was performed as 
described [35]. Briefly, after permeabilization in 
PBS + 1% FBS + 0.25% Triton-X-100, tissues and cells 
were incubated with primary antibodies in staining 
buffer (PBS + 1% FBS) for 1 h at room temperature, 
followed by 1 h incubation fluorochrome-labeled 
secondary antibodies (ALEXA at 1:1000). BrdU-
specific immunostaining required an extra step of 
2 M HCl treatment before permeablization. 
 
Quantification and Statistical Analysis. For 
quantification of immuno-fluorescent images, 25-100 
20x images per replicate were taken on the Molecular 
Devices ImageXpress Micro automated epifluorescence 
imager, followed by automated cell quantification using 
the multiwavelength cell scoring module within the 
MetaXpress analysis software. Data was analyzed, 
using Anova and P values equal or lower than 0.05 were 
considered statistically significant. 
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SUPPLEMENTARY FIGURES 
 
 
 
Supplementary Figure 1. Expression of FGF2  in quiescent muscle  stem
cells from young and old mice.   Muscle stem cells were  isolated from young
and old uninjured muscle, as described in Methods.  The cells were immediately
lysed  for  Western  blotting  without  culturing  and  the  expression  of  FGF2,
phosphor‐ERK1/2,  ERK1/2  and  β‐actin were  analyzed.  30 minutes  of  enhanced
chemiluminescence exposure was used for detection of FGF‐2, while pERK, total
ERK and actin were detected after 2min, 30 sec and 30 sec exposure, respectively.
Low  and  age‐independent  levels  of  FGF‐2  and  pERK were  detected  in  satellite
cells that were derived from uninjured young and old TA muscle. 
 
Supplementary Figure 2. Myogenic marker expression in
young and old muscle stem cells. Muscle stem cell  isolated
from young and old mice were cultured  for 24 hours and  then
immunostained for myogenic markers Pax7 and Myf‐5. ~95% of
isolated young and old satellite cells expressed  these myogenic
markers, demonstrating high and age‐independent purity.    
 
Supplementary Figure 3. Proteinase K treatement abolishes
proliferative hESC factors. Old injury‐activated satellite cells with
associated  myofibers  were  cultured  overnight  in  50%  Opti‐MEM
with 10% old serum and 50% hESC conditioned Opti‐MEM that was
treated  with  pre‐washed  Proteinase  K  agarose  beads  (Sigma‐
Aldrich),  for  1  hour  at  37C  followed  by  bead  removal,  or  mock‐
treated hESC conditioned Opti‐MEM.   Cells received a 2 hour BrdU
pulse  to  label  proliferating  cells  before  cell  fixation.  Immuno‐
fluorescence was performed for Desmin (green) and BrdU (red), with
Hoechst  (blue)  labeling all cell nuclei. Proliferating, desmin+ve cells
were  quantified  by  imaging  and  scoring  multiple  random
microscopic  fields  of  each  condition.  Results  are  displayed  as  the
mean percent of BrdU+,Desmin+ proliferating satellite cell cells +/‐
SEM, p<0.005, n=3 replicate experiments. 
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